Survival curves for DFS and OS in breast cancer patients according to serum CK19-2G2 levels.
- Yanan Kong (384071)
- Junye Wang (384072)
- Wanli Liu (384073)
- Qiaolun Chen (384074)
- Juan Yang (384075)
- Weidong Wei (384076)
- Mingqing Wu (384077)
- Lu Yang (30847)
- Xinhua Xie (384078)
- Ning Lv (384079)
- Jiaoli Guo (384080)
- Laisheng Li (384081)
- Jie Gao (10266)
- Xiaoming Xie (181426)
- Shuqin Dai (384082)
Publication date
March 2013
DOIAbstract
<p>(<b>A</b>) Kaplan-Meier survival curve showed that patients with high serum CK19-2G2 levels (≥2 mU/mL) had a significantly shorter disease free survival(<i>P = </i>0.029) than those with lower levels(<2 mU/mL). (<b>B</b>) Kaplan-Meier survival curve showed that patients with high serum CK19-2G2 levels (≥2 mU/mL) had a significantly shorter overall survival(<i>P = </i>0.040) than those with lower levels(<2 mU/mL).</p
Add to ORKG